Literature DB >> 34611325

Melatonin prevents diabetes mellitus-induced bone loss.

Olivia Tysoe1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34611325     DOI： 10.1038/s41574-021-00581-3

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  1 in total

1.  Exogenous melatonin prevents type 1 diabetes mellitus-induced bone loss, probably by inhibiting senescence.

Authors:  Z Gong; W Da; Y Tian; R Zhao; S Qiu; Q Wu; K Wen; L Shen; R Zhou; L Tao; Y Zhu
Journal:  Osteoporos Int       Date:  2021-09-14       Impact factor: 5.071
  1 in total
  1 in total

1.  Orexin-A Reverse Bone Mass Loss Induced by Chronic Intermittent Hypoxia Through OX1R-Nrf2/HIF-1α Pathway.

Authors:  Hong Gu; Yiwen Ru; Wei Wang; Guanhui Cai; Lanxin Gu; Junjie Ye; Wei-Bing Zhang; Lin Wang
Journal:  Drug Des Devel Ther       Date:  2022-07-05       Impact factor: 4.319
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.